Microgestin Fe 1/20
Product Images NDC 53002-2616

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Microgestin Fe 1/20 (NDC 53002-2616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure of Norethindrone Acetate and Ethinyl Estradiol, the active ingredients in Microgestin Fe 1/20 by RPK Pharmaceuticals, Inc. The two steroid compounds are depicted with labeled chemical bonds and molecular groups.*

FDA Label Image

2 (Image 02)

A table presenting the lowest expected and typical failure rates of various contraceptive methods during the first year of continuous use, showing percentages of women experiencing unintended pregnancy by method, including oral contraceptives, diaphragms, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical caps, periodic abstinence, withdrawal, and sterilization.*

FDA Label Image

3 (Image 03)

A warning text panel indicating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. It notes that this risk rises with age and heavy smoking (15 or more cigarettes daily), especially in women over 35 years, advising against smoking while using oral contraceptives.*

FDA Label Image

4 (Image 04)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' It shows mortality rates for women categorized by age groups (15-24, 25-34, 35-44, 45+), comparing ever-users (non-smokers and smokers) and controls (non-smokers and smokers) of oral contraceptives. The vertical axis indicates mortality rate from 0 to 250 deaths per 100,000 women. The chart highlights higher mortality rates in smokers, especially ever-users in older age groups.*

FDA Label Image

5 (Image 05)

A table showing the annual number of birth-related or method-related deaths associated with fertility control methods per 100,000 nonsterile women by age. It compares different fertility control methods including no method, oral contraceptives for smokers and non-smokers, IUDs, condoms, diaphragm/spermicide, and periodic abstinence across age groups 15-19 through 40-44.*

FDA Label Image

6 (Image 06)

A boxed warning text panel warning that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially in women over 35 years and heavy smokers (15 or more cigarettes per day). It advises women using oral contraceptives not to smoke.*

FDA Label Image

7 (Image 07)

An instructional illustration showing a hand placing a day label sticker (from Sunday to Friday) on a Microgestin Fe 1/20 oral contraceptive blister pack. The diagram explains how to start the pill pack either on the Sunday or day 1 of the menstrual cycle. It highlights pill colors with pale yellow for active pills and brown for inactive pills, and shows the direction to take the pills each week from left to right.*

FDA Label Image

8 (Image 08)

A boxed warning text panel explaining the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking. It specifies higher risk in women over 35 years old and those who smoke 15 or more cigarettes per day, advising women using oral contraceptives not to smoke.*

FDA Label Image

9 (Image 09)

A drug safety warning panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. It highlights increased risk with age and heavy smoking (15 or more cigarettes per day), especially in women over 35 years, and advises women using oral contraceptives not to smoke.*

FDA Label Image

10 (Image 10)

A table showing the annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women, categorized by fertility control method and age group. The methods include no fertility control, oral contraceptives for smokers and non-smokers, IUDs, condoms, diaphragm/spermicide, and periodic abstinence, with data presented for age ranges from 15 to 44 years.*

FDA Label Image

11 (Image 11)

An instructional diagram showing how to start Microgestin Fe 1/20 oral contraceptive pills. It illustrates placing a day label sticker on the pill pack to align with the first day of the menstrual cycle. The diagram highlights the pill-taking sequence direction, from left to right each week, starting at the Sunday or Day 1 marker. Pills are shown in two colors: pale yellow (active) and brown (inactive). A hand is depicted holding the day label strip above the blister pack.*

FDA Label Image

12 (Image 12)

FDA Label Image

Label Image (Lbl530022616)

Microgestin Fe 1/20 tablets 28-count carton label. The label includes usage directions to take one tablet daily as directed. It shows the product name, strength, labeler RPK Pharmaceuticals, Inc., patient and prescriber information fields, barcodes, and billing NDCs. The packaging also lists storage instructions and cautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.